The impact of Hafnia alvei HA4597™ on weight loss and glycaemic control after bariatric surgery — study protocol for a triple-blinded, blocked randomized, 12-month, parallel-group, placebo-controlled clinical trial

Autor: Shámila Ismael, Carlos Vaz, Catarina Durão, Marta P. Silvestre, Conceição Calhau, Diana Teixeira, Cláudia Marques

Publikováno v: Trials, Vol 24, Iss 1, Pp 1-13 (2023)

Abstract Background Subjects with obesity exhibit changes in gut microbiota composition and function (i.e. dysbiosis) that contribute to metabolic dysfunction, including appetite impairment. Although bariatric surgery is an effective treatment for ob

Externí odkaz: https://doaj.org/article/39324f02e3774abb9d3fe25a8ce0d00a

The Probiotic Strain H. alvei HA4597® Improves Weight Loss in Overweight Subjects under Moderate Hypocaloric Diet: A Proof-of-Concept, Multicenter Randomized, Double-Blind Placebo-Controlled Study

Autor: Gregory Lambert, Barbara Grube, Clémentine Trotin-Picolo, Gordana Bothe, Constantin Erlenbeck, Pierre Déchelotte, Jonathan Breton, Sergueï O. Fetissov

Publikováno v: Nutrients
Nutrients, MDPI, 2021, 13 (6), pp.1902. ⟨10.3390/nu13061902⟩
Nutrients, 2021, 13 (6), pp.1902. ⟨10.3390/nu13061902⟩
Volume 13
Issue 6
Nutrients, Vol 13, Iss 1902, p 1902 (2021)

Background: Increasing evidence supports the role of the gut microbiota in the control of body weight and feeding behavior. Moreover, recent studies have reported that the probiotic strain Hafnia alvei HA4597® (HA), which produces the satietogenic p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ce6f8f0faad8ac76ea7914db7729fb
https://hal-normandie-univ.archives-ouvertes.fr/hal-03293871